Related Experiment Video
Updated: Jan 6, 2026

Imaging Approaches to Assessments of Toxicological Oxidative Stress Using Genetically-encoded Fluorogenic Sensors
Published on: February 7, 2018
Macrolide Antibiotics as Modulators of Cellular Oxidative Stress: Mechanisms, Pathways, and Therapeutic Implications
Sandon Ranadeera1, Kelvin G K Goh1, Matthew J Sullivan1,2
1School of Pharmacy and Medical Sciences, and Institute for Biomedicine and Glycomics, Griffith University, Gold Coast Campus, Southport, Queensland, Australia.
Abstract:
Macrolide antibiotics, long recognized for antibacterial properties, have recently emerged as modulators of oxidative stress in eukaryotic cells, reflecting context-dependent effects and pharmacological activities distinct from their antimicrobial activities. The purpose of this review is to examine the capacity and outcomes of macrolides, using erythromycin as the most well-documented example, to modulate responses to stress from reactive oxygen species (ROS) and what this means for redox homeostasis. We compare evidence from studies of mammalian cells and the so-called PI3K/AKT/mTOR and PPARγ/NF-κB/Nrf2 signaling pathways to reveal erythromycin's suppressive effects towards oxidative stress-induced senescence, upregulation of antioxidant enzymes (e.g., superoxide dismutase and catalase), and related effects that mitigate mitochondrial dysfunction. These redox outcomes of exposure to erythromycin are particularly relevant to therapeutic strategies targeting inflammatory and age-related diseases, including chronic obstructive pulmonary disease and neurodegeneration. Conversely, studies of aquatic species, including fish, algae, and invertebrates, suggest that erythromycin induces oxidative damage and genotoxicity. In this review, we discuss factors that are likely to shape this dualistic nature of macrolides in redox modulation such as levels and duration of antibiotic exposure, type of antioxidant system, tissue specificity, and organism complexity. Emerging research in oxidative modulatory properties of erythromycin in eukaryotic and prokaryotic microorganisms, and properties that are shared among macrolides are also discussed. While erythromycin's protective redox effects are therapeutically promising, concerns over chronic use, antioxidant suppression, and other context-dependent outcomes merit the need for systems-level multi-omics approaches to define therapeutic thresholds and ecological risks. This review provides a consolidative overview of our up-to-date understanding of macrolides as redox modulators, and advocates for future investigation into the broad physiological and environmental impacts.
More Related Videos
07:50Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
Published on: October 25, 2024
11:00Methods to Inhibit Bacterial Pyomelanin Production and Determine the Corresponding Increase in Sensitivity to Oxidative Stress
Published on: August 31, 2015
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
The Electron Transport Chain
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Phase I Oxidative Reactions: Overview
Oxygen Requirements and Growth Patterns
Combined Effects of Drugs: Synergism
Such synergistic combinations...